Ligand validation:5KSI

S1P: (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl dihydrogen phosphate

S1P is a Ligand Of Interest in 5KSI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5KSI_S1P_A_203	2%	52%	0.41	0.716	0.81	1.05	1	-	0	0	100%	0.4
5KSI_S1P_D_202	1%	45%	0.444	0.587	0.95	1.18	2	2	10	0	100%	0.4
5KSI_S1P_C_203	0%	41%	0.453	0.574	1.13	1.24	3	1	7	0	64%	0.448
5KSI_S1P_A_202	0%	49%	0.612	0.726	1.02	0.96	1	-	1	0	44%	0.2288
5KSI_S1P_C_202	0%	52%	0.547	0.661	1.11	0.74	1	-	0	0	28%	13.44
5KSJ_S1P_A_202	2%	48%	0.411	0.74	0.85	1.15	-	1	0	0	72%	0.324
2YG2_S1P_A_301	81%	50%	0.121	0.975	1.06	0.88	2	-	3	0	100%	1
3I9G_S1P_L_401	57%	52%	0.187	0.963	0.65	1.19	-	2	0	0	100%	1
7C4S_S1P_A_1001	17%	56%	0.337	0.922	0.57	1.1	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.